Evaluation of the SH-SY5Y cell line as an in vitro model for potency testing of a neuropeptide-expressing AAV vector
Jeanette Zanker, Daniela Hüser, Adrien Savy, Sara Lázaro-Petri, Eva-Maria Hammer, Christoph Schwarzer, Regine Heilbronn · 2023
Read Evaluation of the SH-SY5Y cell line as an in vitro model for potency testing of a neuropeptide-expressing AAV vector by Jeanette Zanker, Daniela Hüser, Adrien Savy, Sara Lázaro-Petri, Eva-Maria Hammer, Christoph Schwarzer, Regine Heilbronn (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10720649.txt.
Description
Jeanette Zanker and six co-authors test a lab cell line as a stand-in for checking gene therapy strength. The therapy uses a virus to carry a gene for a small signaling protein into nerve cells. The protein must be cut to its mature form to work, which makes lab tests tricky. The team used a human nerve-like cell line and varied how much virus the cells got and whether the cells were first matured.
The cells took up the virus well even at low doses, and better once matured. Only matured cells made and released the finished protein in amounts that rose with dose. The paper backs the matured cells as a sound test bed for such vectors.
Catalog record
| CREATOR | Jeanette Zanker, Daniela Hüser, Adrien Savy, Sara Lázaro-Petri, Eva-Maria Hammer, Christoph Schwarzer, Regine Heilbronn |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |